177lu-psma-618
novartis
['lu-177', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
early outcomes from lutetium lu-177 vipivotide tetraxetan treatment in patients selected for therapy with piflufolastat f-18 pet imaging. presented by thomas boike, md . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology